← ANALYST RATINGS · TIPRANKS

Surgery Partners (SGRY): analyst forecast and price target

$14.61 −1.08% close 16.10.26 · market cap $1.9B · Healthcare · Medical - Care Facilities IWM 0.04%
Price targets and ratings of

Analyst consensus

Strong Buy

3 Buy1 Hold0 Sell

Ratings of 4 analysts in the last 3 months · top analysts only

12-month forecast

$19.00+30.0% upside

Based on 4 price targets given in the last 3 months, the average target is $19.00, the highest $24.00, the lowest $15.00. The average is +30.0% from the last price of $14.61.

$15.00$20.00Jan 26AprJulOctJan 27AprJulOctHigh$24.00Average$19.00Low$15.00
Highest target $24.00 Average target $19.00 Lowest target $15.00
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Andrew Mok CFA★★★★★★★★★★#11840 · hits 51% · avg −4.8% Barclays $14.00 Hold −4.2% Reiterated 07.10.26on TipRanks 04:00 +2.5%next day −0.1% · 5 days +9.1%
Ben Hendrix★★★★★★★★★★#1571 · hits 53% · avg +7.2% RBC Capital $19.00 Buy +30.0% Reiterated 29.09.26on TipRanks Sep 30 07:10 −1.7%next day −3.5% · 5 days −8.9%
Joanna Gajuk★★★★★★★★★★#5858 · hits 54% · avg +1.2% Bank of America Securities $20.00 Buy +36.9% Reiterated 18.09.26on TipRanks 07:00 −0.9%next day +1.5% · 5 days +7.4%
Ryan Langston★★★★★★★★★★#9454 · hits 47% · avg −0.6% TD Cowen $19.00 Buy +30.0% Assigned 18.09.26on TipRanks 02:25 −0.9%next day +1.5% · 5 days +7.4%
Benjamin Rossi★★★★★★★★★★#2996 · hits 75% · avg +16.8% J.P. Morgan $14.00 → $15.00+7.1% Hold +2.7% Assigned 14.09.26on TipRanks 07:55 −1.9%next day −2.3% · 5 days −4.6%
Bill Sutherland★★★★★★★★★★#3449 · hits 43% · avg +4.2% Benchmark Co. $24.00 Buy +64.3% Reiterated 11.08.26on TipRanks 14:11 −5.6%next day +1.9% · 5 days −4.7%
Matthew Gillmor CFA★★★★★★★★★★#6184 · hits 53% · avg +2.0% KeyBanc — Hold — Reiterated 11.08.26on TipRanks 04:45 −5.6%next day +1.9% · 5 days −4.7%
Sarah James★★★★★★★★★★#2265 · hits 55% · avg +5.7% Cantor Fitzgerald $18.00 Buy +23.2% Reiterated 10.08.26on TipRanks Aug 11 07:45 +2.7%next day −5.6% · 5 days −9.9%
Ann Hynes★★★★★★★★★★#1003 · hits 59% · avg +8.1% Mizuho Securities $19.00 Buy +30.0% Reiterated 13.07.26on TipRanks 08:16 −1.8%next day −5.7% · 5 days +1.3%
Brian Tanquilut★★★★★★★★★★#1681 · hits 52% · avg +6.6% Jefferies $15.00 → $17.00+13.3% Buy +16.4% Reiterated 06.05.26on TipRanks 14:10 +0.9%next day −1.6% · 5 days −3.1%
A.J. Rice★★★★★★★★★★#690 · hits 61% · avg +9.8% UBS $29.00 → $21.00−27.6% Buy +43.7% Reiterated 10.03.26on TipRanks Mar 11 06:30 −2.5%next day +4.2% · 5 days −1.4%

The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included

Best analysts covering Surgery Partners

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Brian Tanquilut★★★★★★★★★★Jefferies · #1681
Hits 52%257 of 491 Average return +6.6%
1 year Brian Tanquilut★★★★★★★★★★Jefferies · #1681
Hits 52%257 of 491 Average return +6.6%
2 years Brian Tanquilut★★★★★★★★★★Jefferies · #1681
Hits 52%257 of 491 Average return +6.6%

Most profitable

3 months Brian Tanquilut★★★★★★★★★★Jefferies · #1681
Hits 52%257 of 491 Average return +6.6%
1 year Brian Tanquilut★★★★★★★★★★Jefferies · #1681
Hits 52%257 of 491 Average return +6.6%
2 years Brian Tanquilut★★★★★★★★★★Jefferies · #1681
Hits 52%257 of 491 Average return +6.6%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $18.50 at a price of $13.87 (+33.4%); now: $18.43 at $14.61 (+26.1%).

$14.00$16.00$18.00Sep 15Oct 1Oct 15Top analysts$19.00Average target$18.43Price$14.61

PriceAverage targetTop analysts’ target

Recommendation trend · top analysts

051051Oct 25612Nov621Dec521Jan 2611Feb341Mar351Apr371May3Jun3Jul13Aug141Sep131Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy300111
Buy733343
Hold100011
Sell000000

Earnings and sales forecast

Next report: 10.11.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $0.12 (from $0.07 to $0.17). Last quarter: $0.10.

Sales

Next quarter’s sales estimate — $846M (from $816M to $861M). Last quarter: $849M.

Best top-analyst consensus in the sector · Healthcare

AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
About Surgery Partners

Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilities—specifically, 108 ambulatory surgical centers and 18 surgical hospitals—situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.

Data from the stock’s TipRanks forecast page, read 77 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗